Scholar Rock Holding Corporation (FRA:2QK)

Market Cap	4.16B +10.4%
Revenue (ttm)	n/a
Net Income	-301.23M
EPS	-3.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	40.40
Previous Close	39.60
Day's Range	40.40 - 40.40
52-Week Range	21.20 - 40.80
Beta	n/a
RSI	58.73
Earnings Date	Mar 3, 2026

About Scholar Rock Holding

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGFβ) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2012
• Employees: 128
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2QK

Financial Performance

Financial numbers in USD